These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1009 related items for PubMed ID: 23146444

  • 21. Successful transplantation across positive B-cell cross-match in deceased donor renal transplants.
    Goh A, Oei E, Vathsala A.
    Transplant Proc; 2012 Jan; 44(1):193-9. PubMed ID: 22310613
    [Abstract] [Full Text] [Related]

  • 22. Serum flow cytometric C1q binding antibody analysis of renal recipients with low levels of sensitization.
    Ata P, Canbakan M, Kara M, Özel L, Ünal E, Titiz Mİ.
    Transplant Proc; 2012 Jan; 44(6):1652-5. PubMed ID: 22841237
    [Abstract] [Full Text] [Related]

  • 23. Low median fluorescence intensity could be a nonsafety concept of immunologic risk evaluation in patients with shared molecular eplets in kidney transplantation.
    Bosch A, Llorente S, Diaz JA, Salgado G, López M, Boix F, López-Hernández R, González-Soriano MJ, Campillo JA, Moya-Quiles MR, Perez-Lopez N, Minguela A, Jimeno L, Alvarez-López MR, Muro M.
    Hum Immunol; 2012 May; 73(5):522-5. PubMed ID: 22425738
    [Abstract] [Full Text] [Related]

  • 24. Role of human leukocyte antigen, donor-specific antibodies, and their impact in renal transplantation.
    Thiyagarajan UM, Bagul A, Frost J, Horsburgh T, Nicholson ML.
    Transplant Proc; 2012 Jun; 44(5):1231-5. PubMed ID: 22663991
    [Abstract] [Full Text] [Related]

  • 25. Pretransplant immunologic risk assessment of kidney transplant recipients with donor-specific anti-human leukocyte antigen antibodies.
    Marfo K, Ajaimy M, Colovai A, Kayler L, Greenstein S, Lubetzky M, Gupta A, Kamal L, de Boccardo G, Masiakos P, Kinkhabwala M, Akalin E.
    Transplantation; 2014 Nov 27; 98(10):1082-8. PubMed ID: 24873780
    [Abstract] [Full Text] [Related]

  • 26. Detection of donor-specific antibodies using HLA-coated microspheres: another tool for kidney transplant risk stratification.
    Gibney EM, Cagle LR, Freed B, Warnell SE, Chan L, Wiseman AC.
    Nephrol Dial Transplant; 2006 Sep 27; 21(9):2625-9. PubMed ID: 16644776
    [Abstract] [Full Text] [Related]

  • 27. Alloantibodies and the outcome of cadaver kidney allografts.
    Vasilescu ER, Ho EK, Colovai AI, Vlad G, Foca-Rodi A, Markowitz GS, D'Agati V, Hardy MA, Ratner LE, Suciu-Foca N.
    Hum Immunol; 2006 Aug 27; 67(8):597-604. PubMed ID: 16916655
    [Abstract] [Full Text] [Related]

  • 28. Clinical relevance of pre and post-transplant immune markers in kidney allograft recipients: anti-HLA and MICA antibodies and serum levels of sCD30 and sMICA.
    Solgi G, Furst D, Mytilineos J, Pourmand G, Amirzargar AA.
    Transpl Immunol; 2012 Mar 27; 26(2-3):81-7. PubMed ID: 22182633
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Transplantation with positive complement-dependent microcytotoxicity crossmatch in contemporary kidney transplantation: Practice patterns and associated outcomes.
    Graff RJ, Xiao H, Duffy B, Schnitzler MA, Axelrod D, Lentine KL.
    Saudi J Kidney Dis Transpl; 2012 Mar 27; 23(2):234-45. PubMed ID: 22382213
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Clinical significance of low pre-transplant donor specific antibodies (DSA) in living donor kidney recipients with negative complement-dependent cytotoxicity crossmatches (CDCXM), and negative flow cytometry crossmatches (FLXM) - A single-center experience.
    Olszowska-Zaremba N, Gozdowska J, Zagożdżon R.
    Transpl Immunol; 2022 Oct 27; 74():101672. PubMed ID: 35868613
    [Abstract] [Full Text] [Related]

  • 33. Human leukocyte antigen antibody-incompatible renal transplantation: excellent medium-term outcomes with negative cytotoxic crossmatch.
    Higgins R, Lowe D, Hathaway M, Williams C, Lam FT, Kashi H, Tan LC, Imray C, Fletcher S, Chen K, Krishnan N, Hamer R, Daga S, Edey M, Zehnder D, Briggs D.
    Transplantation; 2011 Oct 27; 92(8):900-6. PubMed ID: 21968524
    [Abstract] [Full Text] [Related]

  • 34. Intact HLA not beta2m-free heavy chain-specific HLA class I antibodies are predictive of graft failure.
    Cai J, Terasaki PI, Anderson N, Lachmann N, Schönemann C.
    Transplantation; 2009 Jul 27; 88(2):226-30. PubMed ID: 19623018
    [Abstract] [Full Text] [Related]

  • 35. Aortic valve allograft structural deterioration is associated with a subset of antibodies to human leukocyte antigens.
    Dignan R, O'Brien M, Hogan P, Thornton A, Fowler K, Byrne D, Stephens F, Harrocks S.
    J Heart Valve Dis; 2003 May 27; 12(3):382-90; discussion 390-1. PubMed ID: 12803340
    [Abstract] [Full Text] [Related]

  • 36. Preformed donor-specific antibodies and risk of antibody-mediated rejection in repeat renal transplantation.
    Tsapepas DS, Vasilescu R, Tanriover B, Coppleson Y, Rekhtman Y, Hardy MA, Dube G, Crew RJ, Ratner LE, Cohen DJ, Mohan S.
    Transplantation; 2014 Mar 27; 97(6):642-7. PubMed ID: 24637863
    [Abstract] [Full Text] [Related]

  • 37. Sensitivity, specificity and clinical relevance of different cross-matching assays in deceased-donor renal transplantation.
    Ho EK, Vasilescu ER, Colovai AI, Stokes MB, Hallar M, Markowitz GS, D'Agati VD, Cohen DJ, Ratner LE, Suciu-Foca N.
    Transpl Immunol; 2008 Nov 27; 20(1-2):61-7. PubMed ID: 18929659
    [Abstract] [Full Text] [Related]

  • 38. Inferior kidney allograft outcomes in patients with de novo donor-specific antibodies are due to acute rejection episodes.
    Cooper JE, Gralla J, Cagle L, Goldberg R, Chan L, Wiseman AC.
    Transplantation; 2011 May 27; 91(10):1103-9. PubMed ID: 21403588
    [Abstract] [Full Text] [Related]

  • 39. Solid phase detection of C4d-fixing HLA antibodies to predict rejection in high immunological risk kidney transplant recipients.
    Bartel G, Wahrmann M, Schwaiger E, Kikić Ž, Winzer C, Hörl WH, Mühlbacher F, Hoke M, Zlabinger GJ, Regele H, Böhmig GA.
    Transpl Int; 2013 Feb 27; 26(2):121-30. PubMed ID: 23145861
    [Abstract] [Full Text] [Related]

  • 40. Post-transplant DSA monitoring may predict antibody-mediated rejection in sensitized kidney transplant recipients.
    Mohamed MA, Muth B, Vidyasagar V, Foley D, Fernandez L, Hofmann RM, Mezrich J, Pirsch J, Odorico J, d'Alessandro T, Bellingham J, Torrealba J, Kaufman D, Djamali A.
    Clin Transpl; 2011 Feb 27; ():389-94. PubMed ID: 22755436
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 51.